September 12, 2025

FDA Considers Ending Routine Advisory Committees on New Drugs

The FDA move to limit advisory committee involvement in drug approvals has prompted debate on the balance between efficiency and transparency.

KFF Health News

September 12, 2025

Is Alopecia Areata a Marker of Elevated Cardiovascular Risk?

While alopecia has several verified comorbidities, the potential correlation with cardiovascular disease warrants further investigation.

Conexiant

September 12, 2025

Cemiplimab Reduces Recurrence in High-Risk cSCC

First adjuvant immunotherapy trial shows 23% absolute reduction in recurrence for resected cutaneous squamous cell carcinoma.

Conexiant

September 12, 2025

Maternal Health and Vitiligo: First Scoping Review Protocol

Protocol outlines review of vitiligo pregnancy outcomes, methods, and planned data mapping.

Conexiant

September 12, 2025

Dual-Mode Optical System Sharpens Skin Cancer Diagnosis

AI-assisted imaging merges structure and chemistry for noninvasive classification of nonmelanoma cancers

The Analytical Scientist

September 08, 2025

HS Severity Scores Declined With GLP-1 Use

Glucagon-like peptide-1 receptor agonists are linked to consistent hidradenitis suppurativa improvements across symptom, quality-of-life, and weight outcomes.

Conexiant

September 05, 2025

One Dose of Benzathine Penicillin Noninferior for Early Syphilis

Most patients reported local injection-site pain, but serious adverse events were rare and unrelated to benzathine penicillin G treatment.

Conexiant

September 03, 2025

Vitiligo Depression Risk Varies by Race

Analysis of national health records shows vitiligo is linked to higher depression odds in certain racial and ethnic groups, highlighting variation in mental health burden across populations.

Conexiant

September 03, 2025

Study Maps Delta-Like Protein 3 and SEZ6 Across Tumor Types

Researchers highlight distinct Delta-like protein 3 and seizure-related 6 homolog patterns in neuroendocrine tumors.

Conexiant